[HTML][HTML] Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology
The blood-brain barrier (BBB) constitutes a microvascular network responsible for excluding
most drugs from the brain. Treatment of brain tumors is limited by the impermeability of the …
most drugs from the brain. Treatment of brain tumors is limited by the impermeability of the …
[HTML][HTML] Modulation of immune responses by particle size and shape
The immune system has to cope with a wide range of irregularly shaped pathogens that can
actively move (eg, by flagella) and also dynamically remodel their shape (eg, transition from …
actively move (eg, by flagella) and also dynamically remodel their shape (eg, transition from …
[HTML][HTML] Advances in nanomaterial-based targeted drug delivery systems
X Cheng, Q Xie, Y Sun - Frontiers in bioengineering and …, 2023 - frontiersin.org
Nanomaterial-based drug delivery systems (NBDDS) are widely used to improve the safety
and therapeutic efficacy of encapsulated drugs due to their unique physicochemical and …
and therapeutic efficacy of encapsulated drugs due to their unique physicochemical and …
[HTML][HTML] Simulation of nanoparticles interacting with a cell membrane: probing the structural basis and potential biomedical application
X Zhang, G Ma, W Wei - NPG Asia Materials, 2021 - nature.com
Nanoparticles (NPs), owing to their ultrasmall size, have been extensively researched for
potential applications in biomedicine. During their delivery and functionalization within the …
potential applications in biomedicine. During their delivery and functionalization within the …
Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood–brain barrier
Y Wei, X Xia, H Li, H Gao - Expert Opinion on Drug Delivery, 2023 - Taylor & Francis
Introduction A major challenge in treating central nervous system (CNS) disorders is to
achieve adequate drug delivery across the blood–brain barrier (BBB). Receptor-mediated …
achieve adequate drug delivery across the blood–brain barrier (BBB). Receptor-mediated …
[HTML][HTML] Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives
Alzheimer's disease (AD), the most common form of dementia, is a progressive and
multifactorial neurodegenerative disorder whose primary causes are mostly unknown. Due …
multifactorial neurodegenerative disorder whose primary causes are mostly unknown. Due …
[HTML][HTML] Harnessing role of sesamol and its nanoformulations against neurodegenerative diseases
Sesamol is a lignan of sesame seeds and a natural phenolic molecule that has emerged as
a useful medical agent. Sesamol is a non-toxic phytoconstituent, which exerts certain …
a useful medical agent. Sesamol is a non-toxic phytoconstituent, which exerts certain …
Recent Advances in the Development of Near-Infrared Fluorescent Probes for the in Vivo Brain Imaging of Amyloid-β Species in Alzheimer's Disease
The deposition of β-amyloid (Aβ) plaques in the parenchymal and cortical regions of the
brain of Alzheimer's disease (AD) patients is considered the foremost pathological hallmark …
brain of Alzheimer's disease (AD) patients is considered the foremost pathological hallmark …
Advances in designing of polymeric micelles for biomedical application in brain related diseases
In recent years, unique physicochemical properties of amphiphilic block copolymers have
been utilized to design the polymeric micelles for brain-specific delivery of drugs, proteins …
been utilized to design the polymeric micelles for brain-specific delivery of drugs, proteins …
Interaction of 2D nanomaterial with cellular barrier: membrane attachment and intracellular trafficking
L Miao, Y Wei, X Lu, M Jiang, Y Liu, P Li, Y Ren… - Advanced Drug Delivery …, 2023 - Elsevier
The cell membrane serves as a barrier against the free entry of foreign substances into the
cell. Limited by factors such as solubility and targeting, it is difficult for some drugs to pass …
cell. Limited by factors such as solubility and targeting, it is difficult for some drugs to pass …